Please enable JavaScript or talk to your local administrator to get JavaScript enabled.

Project

Chimeric RNAs and their implication in lymphatic metastasis of bladder cancer

Funder: National Cancer Institute

Funding period
USD 206 K
Funding amount
Abstract
PROJECT SUMMARY Bladder cancer represents a common malignancy worldwide. The main cause of death in bladder cancer patients is metastasis, with lymphatic metastasis as the primary means. Metastatic bladder cancer is currently difficult to remove completely, and not sensitive to radiotherapy and chemotherapy. Better understanding and exploitation of new diagnostic and therapeutic strategy for lymphatic metastasis of bladder cancer is urgently needed. The study of gene fusions has founded the theoretical backgrounds for many cancer diagnosis and therapeutics. However, even with whole genome sequencing, novel recurrent gene fusions are rarely identified in bladder cancer. Recently, our work on RNA trans-splicing and intergenic cis-splicing have helped open a new paradigm for intergenic splicing processes that generate chimeric RNAs with pro-tumorigenic activities, and may explain the molecular basis of the presence of driver onco-fusion products in the absence of chromosomal rearrangement at the DNA level. Indeed, in our preliminary studies, we have identified several chimeric RNAs unique to bladder cancer, but produced by intergenic splicing. Within a month since the issue of the RFA, together with our Chinese collaborators, we have successfully identified a few chimeric RNAs that are differentially expressed in lymph node metastatic group using only partial data. This success plus our past fruitful collaboration encouraged us to propose the following aims: 1. To identify of chimeric RNAs associated with lymphatic metastasis of bladder cancer by combining the RNA-Sequencing data from TCGA and China. By integrating with CPTAC and whole genome sequencing data associated with TCGA, we can determine whether the chimeric RNAs may code for chimeric protein, and whether they are products of gene fusion or intergenic splicing. Using the clinical information from TCGA and Chinese patients, we will reveal the relationship between chimeric RNAs and lymphatic metastasis, disease progression, and prognosis; 2. To investigate the role of the chimeric RNAs in lymphatic metastasis of bladder cancer cells, and to elucidate the molecular mechanism of the chimeric RNAs in regulating lymphatic metastasis of bladder cancer; We will focus on two groups of chimeric RNAs, fusion protein-coding and long non-coding chimeric RNA (lnccRNA). 3. To explore the significance of chimeric RNA as an early diagnostic marker, prognostic factor, and therapeutic target for lymphatic metastasis of bladder cancer. We will investigate the potential of the candidate chimeric RNAs as biomarkers, and nanoparticle delivery of siRNAs to target key chimeric RNAs; and 4) To develop an interactive web-based database to disseminate the results. The proposed study fits the NCI Funding Priorities, Genomics/Epigenomics/Transcriptomics/Proteomics, in that we will combine the large multi-omics data from both countries, analyze the landscape of chimeric RNAs, and investigate their roles as protein-coding, or long non-coding in lymph node metastasis of bladder cancer. !
Similar projects All >
Sorted by: Start Date
Project list item
Characterization of Nectin-4 expression in molecular subtypes of urothelial cancer and mechanisms of resistance to enfortumab vedotin

Bladder Cancer Advocacy Network to Carissa Ellen Chu

USD 1,700
2020 - 2020
Project list item
Defining NRF2 induced tumor invasion in bladder cancer

Bladder Cancer Advocacy Network to Yuki Kita, William Youngkwan Kim, Bernard Weissman

USD 50,000
2020 - 2021
Project list item
Dissecting myeloid cell-mediated resistance to immune checkpoint blockade in bladder cancer

National Cancer Institute to NINA BHARDWAJ, JUN ZHU, MATTHEW GALSKY

USD 703,400
2020 - 2025
Project list item
Implication of neutrophil extracellular traps in the efficacy of bladder-sparing therapy in muscle invasive bladder cancer

Canadian Institutes of Health Research to Wassim Kassouf, Jonathan David Spicer, Ciriaco A. Piccirillo

USD 138,878
2020 - 2025
Project list item
A new bladder cancer model based on tissue reprogramming and gene targeting

National Cancer Institute to FLAMINIA TALOS, DAIFENG WANG

USD 203,843
2020 - 2021

System

Categories
  • FOR (ANZSRC)

    0604 Genetics

  • FOR (ANZSRC)

    1112 Oncology and Carcinogenesis

  • RCDC

    Biotechnology

  • RCDC

    Human Genome

  • RCDC

    Cancer

  • RCDC

    Clinical Research

  • RCDC

    Genetics

  • RCDC

    Urologic Diseases

  • HRCS HC

    Cancer

  • HRCS RAC

    2.1 Biological and endogenous factors

  • Health Research Areas

    Biomedical

  • Broad Research Areas

    Basic Science